Status:
RECRUITING
Feasibility of Prospective Surveillance and Early Physical Therapy for Trismus
Lead Sponsor:
University of Alberta
Collaborating Sponsors:
Alberta Health services
Conditions:
Head and Neck Cancer
Trismus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Trismus, or restricted jaw movement, can occur in individuals with head and neck cancer (HNC) undergoing surgery or radiation therapy. There is a paucity of research examining interventions for trismu...
Detailed Description
1. Background and rationale : Head and neck cancers (HNCs) originate in the nasal cavity, sinuses, lips, mouth, salivary glands, throat, and larynx. Individuals undergoing treatment for HNC often deve...
Eligibility Criteria
Inclusion
- Have a diagnosis of oral, oropharyngeal, or nasopharyngeal cancer
- Be scheduled to undergo cancer treatment that includes radiation therapy
- Be able to read and understand English
- Be an Alberta resident.
Exclusion
- Previous surgery for the temporomandibular joint that is not related to the HNC diagnosis.
- Local cancer recurrence or metastatic disease.
- Unable to provide informed consent.
Key Trial Info
Start Date :
March 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06531083
Start Date
March 1 2025
End Date
May 31 2026
Last Update
March 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alberta/ Cross Cancer Institute
Edmonton, Alberta, Canada, T6G 2G4